Clinical Trial Update: Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating oral erythromycin for the Dowling-Meara type Epidermolysis Bullosa Simplex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa
• Epidermolysis Bullosa Simplex

Drugs mentioned

• ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Epidermolysis Bullosa | Phase 3 | Status: UNKNOWN